Molecular crystal redox device for pharmaceuticals

Details Molecular crystal redox device for pharmaceuticals Molecular crystal redox device for pharmaceuticals

1994-08-04

1996-11-05

Hulina, Amy

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Biocides; animal or insect repellents or attractants

424618, 423604, 514495, A61K 3338

Patent

active

055715206

ABSTRACT:
The employment of molecular crystals as bactericidal, viricidal and algicidal devices, and specifically the molecular semiconductor crystal tetrasilver tetroxide Ag.sub.4 O.sub.4 which has two trivalent and two monovalent silver atoms per molecule, and which through this structural configuration generates electronic activity on a molecular scale capable of killing algae and bacteria via the same mechanism as macroscale electron generators.

REFERENCES:
patent: 4055655 (1977-10-01), Maurer et al.
patent: 4695353 (1987-09-01), Jansen et al.
patent: 4717562 (1988-01-01), Jansen et al.
patent: 4784991 (1988-11-01), Nimrod et al.
patent: 4835077 (1989-05-01), Megahed et al.
patent: 4915955 (1990-04-01), Gomori
patent: 4952411 (1990-08-01), Fox, Jr. et al.
patent: 5017295 (1991-05-01), Antelman
patent: 5073382 (1991-12-01), Antelman
patent: 5078902 (1992-01-01), Antelman
patent: 5089248 (1992-02-01), Akhtar
patent: 5089275 (1992-02-01), Antelman
patent: 5098582 (1992-03-01), Antelman
patent: 5211855 (1993-05-01), Antelman
patent: 5223149 (1993-06-01), Antelman
patent: 5336508 (1994-08-01), Marty
patent: 5362735 (1994-11-01), Luengo
patent: 5444052 (1995-08-01), Pieringer et al.

Affiliated with

Also associated with

Rating

Molecular crystal redox device for pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Molecular crystal redox device for pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular crystal redox device for pharmaceuticals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2013243